antihemophilic factor

(redirected from Kogenate FS)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to Kogenate FS: Xyntha

an·ti·he·mo·phil·ic factor

 (ăn′tē-hē′mə-fĭl′ĭk, ăn′tī-)
n. Abbr. AHF
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.antihemophilic factor - a coagulation factor (trade name Hemofil) whose absence is associated with hemophilia Aantihemophilic factor - a coagulation factor (trade name Hemofil) whose absence is associated with hemophilia A
clotting factor, coagulation factor - any of the factors in the blood whose actions are essential for blood coagulation
References in periodicals archive ?
M2 EQUITYBITES-May 12, 2014-Bayer receives approval from US FDA for Kogenate FS antihemophilic factor VIII (recombinant) for routine prophylaxis in adults with hemophilia A
M2 PHARMA-May 12, 2014-Bayer receives approval from US FDA for Kogenate FS antihemophilic factor VIII (recombinant) for routine prophylaxis in adults with hemophilia A
The drug Kogenate FS is the next generation blood-clotting factor that helps hemophiliacs survive.
NovoSeven, Xyntha and Kogenate FS are the main drugs available to treat hemophilia.
LIPLONG is a randomised, double-blind active comparator controlled study designed to demonstrate the non-inferiority of BAY79-4980 infused in hemophilia A patients once a week as compared with Kogenate FS, antihemophilic factor (recombinant), which is infused three times per week.